This federal contract award, valued at $5,450.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566687589 - CYCLOSPORINE 0.05% EYE EMULS 30S, with a completion date of December 12, 2024.
The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
This specific delivery order was awarded on a Firm Fixed Price basis and did not utilize any set-aside designation, indicating open competition. Amerisourcebergen's extensive federal contract portfolio demonstrates its critical role in supplying essential pharmaceutical and medical products to various government agencies, particularly within the military and veterans' healthcare systems.
Generated 3/12/25, 10:09 AM